Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

S. Stensen; L. S. Gasbjerg; M. M. Rosenkilde; B. Hartmann; T. Vilsboll; J. J. Holst; M. B. Christensen; F. K. Knop

Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

S. Stensen, L. S. Gasbjerg, M. M. Rosenkilde, B. Hartmann, T. Vilsboll, J. J. Holst, M. B. Christensen, F. K. Knop

Originalsprog	Engelsk
Publikationsdato	sep. 2021
Status	Udgivet - sep. 2021

Citationsformater

@conference{122f10befb1740a98060473540a5e39e,

title = "Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes",

author = "S. Stensen and Gasbjerg, \{L. S.\} and Rosenkilde, \{M. M.\} and B. Hartmann and T. Vilsboll and Holst, \{J. J.\} and Christensen, \{M. B.\} and Knop, \{F. K.\}",

year = "2021",

month = sep,

language = "English",

pages = "95--95",

}

TY - ABST

T1 - Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

AU - Stensen, S.

AU - Gasbjerg, L. S.

AU - Rosenkilde, M. M.

AU - Hartmann, B.

AU - Vilsboll, T.

AU - Holst, J. J.

AU - Christensen, M. B.

AU - Knop, F. K.

PY - 2021/9

Y1 - 2021/9

M3 - Conference abstract for conference

SP - 95

EP - 95

ER -